Product Information
NEFFY 2 MG/0.1 ML NASAL SPRAY is a brand product labeled by ARS Pharmaceuticals Operations, Inc., priced at $359.4923 per EA under NDC 82580002002. Its NADAC has been published 85 times since Feb 19, 2025.
FDA first approved this application on Aug 9, 2024.
Strength
2 mg/100uL
Manufacturer
ARS Pharmaceuticals Operations, Inc.NDC
82580002002
Classification
Brand
Dosage Form
SPRAY
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
EPINEPHRINEApproval Type
New Drug (NDA)
FDA Application
NDA214697FDA Approved
8/9/2024
On Market Since
8/9/2024
Pharmacological Classes
Price Statistics
The NADAC for NEFFY 2 MG/0.1 ML NASAL SPRAY has been published 85 times since Feb 19, 2025, and over the history we have for it it has risen 6.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $359.4923 per EA |
|---|---|
| All-time high | $359.8986 (May 13, 2026) |
| All-time low | $338.9925 (May 21, 2025) |
| 52-week high | $359.8986 |
| 52-week low | $339.5206 |
| Median price | $339.7939 |
| Average price | $348.4916 |
| Largest weekly change | +6.0% (Jan 14, 2026) |
| Weeks tracked | 85 |
| Tracking since | Feb 19, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the epinephrine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ARS Pharmaceuticals Operations, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
epinephrine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Catecholamine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NEFFY 2 MG/0.1 ML NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for NEFFY 2 MG/0.1 ML NASAL SPRAY, manufactured by ARS Pharmaceuticals Operations, Inc., is $359.4923 per EA (NDC 82580002002), effective Sep 30, 2026.
How has the price of NEFFY 2 MG/0.1 ML NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for NEFFY 2 MG/0.1 ML NASAL SPRAY has risen 6.0%. It has been tracked across 85 weekly CMS publications since Feb 19, 2025.
What are the highest and lowest recorded NADAC prices for NEFFY 2 MG/0.1 ML NASAL SPRAY?
Since Feb 19, 2025, the NADAC for NEFFY 2 MG/0.1 ML NASAL SPRAY has ranged from a low of $338.9925 (May 21, 2025) to a high of $359.8986 (May 13, 2026), with a median of $339.7939 per EA.
Are there cheaper alternatives to NEFFY 2 MG/0.1 ML NASAL SPRAY?
No other NADAC-published product currently shares the active ingredient and strength of NEFFY 2 MG/0.1 ML NASAL SPRAY in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NEFFY 2 MG/0.1 ML NASAL SPRAY?
NEFFY 2 MG/0.1 ML NASAL SPRAY (NDC 82580002002) is labeled by ARS Pharmaceuticals Operations, Inc., and CMS classifies it as a brand product.